MOTS DES PRÉSIDENTS

 

 

Comité de pilotage du congrès LM4MS

Prof. Michael Neumaier

 

 

 

 

 

 

 

 

    

Comité de pilotage du congrès LM4MS

 

Dear Colleagues,

I am honored to welcome you to this very special 1st EFLM/AFCB Conference on “Laboratory Medicine for Mobile Societies”. This conference is a result of the strategic collaboration - designated “Laboratory Medicine for Mobile Societies” (LM4MS) – forged between EFLM and AFCB, two of the Regional Federations within the International Federation of Clinical Chemistry (IFCC). LM4MS is grateful for the support and the continuous input that IFCC has provided for our concept. We also are indebted to the Tunesian Society for Clinical Biology (STBC) for the enthusiasm to host this first conference.

While the planning for this 1st congress was well on its way in early 2020, mankind has been struck by the COVID-19 Pandemic, which so far has affected 100 million individuals and caused well over 2 million deaths. In an unprecedented effort of international scientific, medical and political collaborations, the world is still working to contain the disease and to mitigate its effects. One year into the COVID-19 Pandemic, we are being reminded on a daily basis, how health systems and their resilience are impacted by mobility.

Through their joint LM4MS Task Force, EFLM and AFCB recognize the  diagnostic challenges associated with an increasing mobility of their citizens not only within the Federations´ borders. We also experience that migration and getaway movements - as consequences of unrest and violence, socio-political instability and war - often leave the victims in desperate need for health care. This need not only exists while crossing through the Mediterranean region representing the geographical interface between the two Federations, but also beyond the points of entry and the continued migrations through the Federations´ territories.

Clinical Chemistry and Laboratory Medicine can play an important role for monitoring health and disease during these processes as the diagnostic tools are available to answer to the medical needs. Together with the rapid evolution of digitalized medicine, the field can address the challenges of monitoring health and disease in mobile societies and people migration by networking health care professionals within the Mediterranean region and beyond. We are urged to recognize the societal importance of working together on issues of mutual interest. LM4MS shall be a first effort to connect EFLM´s and AFCB´s realm of expertise and professional activities to meet these tasks.

Dear colleagues, while it is a pity that we will not be able to meet in person to discuss the important issue of Medical Diagnostics in mobile societies, I am confident that the web-based virtual conference format, we are confined to at present, will add important digital facets to LM4MS communication activities and hopefully further the LM4MS mission.

 

 

Président du congrès

Pr. Taieb Ben Messaoud 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Président du congrès

 

Madame la présidente de  la Fédération Européenne de Chimie Clinique et Médecine de Laboratoire (EFLM)

Monsieur le président de  la Fédération Arabe de Biologie Clinique (AFCB)

Monsieur le président de la Fédération Internationale de Chimie Clinique et Médecine de Laboratoire (IFCC).

Chers collègues, chers participants au congrès, chers partenaires,

 

L’évolution récente de la situation sanitaire liée à la pandémie de Covid-19 a contraint le gouvernement à interdire la tenue d’événements scientifiques en Tunisie. Cette année a été particulièrement difficile, difficile en termes de santé, difficile pour notre pays, et plus généralement pour tous les pays touchés par cette pandémie.

C’est avec un grand plaisir que nous vous annonçons  que la Société Tunisienne de Biologie Clinique (STBC), la Fédération Européenne de Chimie Clinique et Médecine de Laboratoire (EFLM) et la Fédération Arabe de Biologie Clinique (AFCB) organisent le 1er congrès Arabo-Européen (LM4MS) et les XXXIVèmes Journées Nationales de Biologie Clinique sous format virtuel et ce du 18 au 20 Février 2021.Cette manifestation est placée sous les auspices de la Fédération Internationale de Chimie Clinique et Médecine de Laboratoire (IFCC).

Aux congressistes des différents pays du monde que nous attendons nombreux du 18 au 20 Février 2021, à nos partenaires et à nos collaborateurs : mille mercis d’avoir choisi notre congrès. Nous avons hâte de vous voir participer à notre congrès.

Nous saluons également l’implication des membres du comité organisateur. Chacune et chacun d’entre vous a insufflé sa vision et son souci d’offrir un évènement enrichissent et de qualité, à tous les égards.

Nous tenons à remercier tous les partenaires qui ont prêté main forte à la mise en place de ce congrès, dont la pertinence n’est plus à discuter.

Le programme scientifique est riche et touche différents volets du thème principal du congrès, à savoir « Santé et mobilité ». Le programme des XXXIV èmes journées nationales  de biologie clinique  vise à offrir un cadre d’échanges aux différents participants en vue de dynamiser la biologie clinique dans notre pays avec la création de nouveaux réseaux thématiques.

Sept  symposiums, six  conférences plénières et une table ronde sont programmés.

Le XIIème cours de biologie moléculaire, aujourd’hui devenu une tradition et organisé en pré-congrès, comporte 3 conférences : Le séquençage de nouvelle génération et ses applications en biologie clinique, la nutrigénétique dans le domaine des maladies métaboliques, obésité et maladies cardiovasculaires et la bioinformatique appliquée à la biologie moléculaire.

Des conférenciers de renommée internationale (Allemands, Français, Grecs, Italiens, Libanais, Syriens, Saoudiens, Algériens, Marocains et Tunisiens) animeront les conférences plénières et les symposiums élaborés par un comité scientifique international.

Dans le but d’encourager et d’impliquer les jeunes biologistes, une session IFCC-Task Force Young Scientists est programmée au cours de ce congrès Arabo-Européen.

 Au cours de ce congrès en mode virtuel, vous aurez l’occasion d’avoir des échanges d’expériences riches sur le plan professionnel.

Enfin, je voudrais remercier tous ceux qui ont contribué à la réussite de ce congrès, notamment les membres du bureau de la STBC, le comité scientifique, le comité d’organisation, les conférenciers, les modérateurs de séances et le jury d’évaluation des posters. Je remercie également  la société MICE Travel, organisateur professionnel de ce congrès ainsi que tous nos partenaires industriels et  tous ceux qui ont, de prés ou de loin, contribué à l’organisation de ce congrès. Au nom de tout le bureau de la STBC, je souhaite à ce congrès beaucoup de réussite.

 

Présidente de L'EFLM

Prof. Ana-Maria Šimundic

 

    

Présidente de l'EFLM

 

Dear colleagues, dear participants, dear friends,

thank you for offering me the opportunity to welcome you all to the 1st EFLM-AFCB Conference, on behalf of EFLM.

This conference is a result of the joined efforts of our Federations. This conference demonstrates that two Federations can join, work together and collaborate successfully on topics of mutual interest, as are certainly the many challenges of mobile societies for laboratory medicine across the Mediterranean Sea. This conference is, I hope, a beginning of a wonderful friendship between our two Federations and I hope just one of the many successful joint projects to some.

The program of this conference addresses many challenges of laboratory medicine, which occur as a result of the increasing mobility of the citizens of our two Federations across the Mediterranean – the geographical interface between the Federations.

Please allow me to extend my sincere congratulations to the scientific and organizing committees for the fantastic work in putting up such a great conference.

I am very much looking forward to it and I am sure it will be a success.

Thank you.

 

 

Président de L'AFCB

Dr. Osama Najjar

 

 

 

    

Président de l'AFCB

 

Dear Colleagues and Friends,

On behalf of the AFCB executive board I send you my greetings on the occasion of the 1st EFLM/AFCB Conference Laboratory Medicine for Mobile Societies. This conference as one of the practical cooperation between AFCB and EFLM highlights the role of laboratories in mobile societies.

The great efforts that established for organizing this conference were thankful efforts. The role of the Tunisian Society of Clinical Biology (STBC) was the spearhead in holding this conference due to their commitment, enthusiasm, and determination to succeed which represents a success story in joint cooperation between reginal federations in the IFCC.

Our friends from the EFLM gave their utmost efforts in planning, guidance and follow up for the success of the conference. These efforts continue to build bridges of knowledge, science, medicine and love for the sake of human health. The enthusiasm of our colleges from EFLM was of great importance in building a sustainable strategic relationship between AFCB and EFLM. 

This conference which will be held under the circumstances of Corona Pandemic impose special procedures on the organizing committee to overcome the challenges in holding it virtual. The symposium program including multidisciplinary lectures concerning different topics about laboratory medicine in mobile societies and the great effect of lab. Medicine in the health of these societies. These challenges were the driving force for the achievement of holding the conference. 

Finally, with my great delight I welcome you to this conference in Tunisia, wishing the success of this conference.                                         

Sincerely

 

 

Président de l'IFCC

Prof. Khosrow Adeli

 

    

Président de l'IFCC

 

It is my great pleasure to present this welcoming message to all national and international conference participants of this special conference. This joint conference between the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the Arab Federation of Clinical Biology (AFCB) sets the stage for a truly international and collaborative event and presents a unique opportunity to bring leading experts and industry partners together on a global virtual platform to discuss the latest findings and advances in laboratory medicine, clinical chemistry, clinical biology, and epidemiology, with focuses on COVID-19 and migration.

The IFCC organization is pleased to partner with both the EFLM and AFCB on this important event to support scientific exchange and the harmonization of scientific, educational, and professional efforts. As the IFCC continues to expand its international reach, we remain committed to the key goal of advancing better healthcare worldwide, primarily through advancements in laboratory medicine. In order to optimize laboratory medicine, and thus healthcare, it is essential to understand the context in which it operates, such as the epidemiological patterns related to migration and the on-going COVID-19 pandemic. To ensure continued growth and development of our field, we need to encourage a culture of innovation contributing to technological and process innovations, while also ensuring that we consider how those innovations can support healthcare in the context of our external environment. This will allow us to meet the future needs of our patients and healthcare systems.

I hope you all enjoy the excellent scientific program organized by the EFLM and AFCB. With a wide-breadth of timely topics, this event is sure to stimulate interesting conversation, ideas, and, ultimately, new discoveries in the near future.

 

 

Comité de pilotage du congrès LM4MS

Dr. Alexander Haliassos

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Comité de pilotage du congrès LM4MS

 

Dear Colleagues and Friends,

Thank you to each and every one of you for being here with us today. We are very pleased to be able to welcome you to our first LM4MS conference.

As you probably know, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the Arab Federation of Clinical Biology (AFCB) had recognized the importance of working together in order to collaborate on specific issues that have been identified as being mutually important in both Federations´ realm of expertise and professional activities. Especially they recognized that today´s societies are characterized by an increasing mobility of their citizens within the Federations´ borders, and also across the Mediterranean region defining the geographical interface between the two Federations.

As we all know migration and getaway movements are the consequence of unrest, war, socio-political instability and recently exploding pandemics, often leaving the victims in desperate need for health care not only upon entering our member countries, but also beyond their point of entry during their continued migration through the Federations´ territories.

In consequence, EFLM and AFCB recognized the importance of jointly supporting the evolution of comprehensive laboratory strategies in the context of mobile societies and people migration by networking health care Professionals in the Mediterranean region organize jointly this conference.

Last year has been a hard year and the interest has shifted mostly to SARS-CoV-2, however I am thankful that we made this conference a reality despite all the obstacles, although we are organized this conference in all virtual form for obvious reasons.

With everyone struggling, it is comforting that we are still dedicating time to the people in most need. There are many great challenges that the refuges face every day and with the pandemic still raging their problems have been multiplied. With the virus thriving under the crowded conditions the mobile societies face, the situation has been devastating to them. We believe it is appropriate that we focus on the most pressing health issue for the refuges themselves, the coronavirus. Coping with it is a great challenge for everyone, and especially for the refuges who lack the infrastructure and the space to social distance.

Today, just after the opening in a Symposum we will discuss about the Epidemiology and public health care interventions and our plenary lecture has as subject the Mobile societies in the digitalization area as a structural challenge to laboratory medicine.

Tomorrow our agenda starts with the plenary lecture about Migration and genetics followed by a Symposium on Migration and emerging infectious diseases. The first afternoon Symposium presents the latest developments in Laboratory diagnosis of COVID-19 followed by the afternoons plenary on an evidence-based approach for the management of COVID-19 in Tunisia and the key role of INEA Santé followed by a Symposium on the important problem of Migration and drug addiction. During the closing Symposium of the second day the IFCC Young Scientists Task force Session will present us how the Young scientists confront the COVID-19 pandemic.

The final day of our conference starts with a plenary lecture on Targeted therapies and companion diagnostic tests followed by a plenary presentation of Late hemolytic reaction and transfused-related hyperhemolysis in sickle cell disease. The next two symposia present the News on the diagnosis and management of acute coronary syndromes and a Professional view on the new nomenclature of medical biology tests in Tunisia. The closing plenary of our conference presents the important issue of Physiopathological mechanisms of thrombotic events linked to COVID-19

Dear Colleagues and friends, many countries in our region have struggled with the pandemic, however new scientific developments and a better understanding of the virus, as will be presented the following days, have brought us hope for the future. It is a privilege and an honor to hold this conference with you. It has been a tough period and the end of the pandemic seems to be near.

Dear colleagues and friends I hope next time I will be able to embrace each one of you at a face-to-face meeting. 

 

Président du comité scientifique LM4MS

Pr. Abderrazek Hedhili

 

 

 

 

 

    

 

Président du comité scientifique LM4MS

 

This first EFLM / AFCB LM4MS congress is the culmination of 3 years of intense efforts by persons who believed in this great collaborative project between our two EFLM / AFCB Federations. Despite the worrying world situation, the organization of this congress, even virtual and especially during this critical period, is a challenge for all of us and allows us to show our solidarity and to overcome this disastrous pandemic. This congress will be held in an exceptional international context dominated by the Covid-19 pandemic

Around the mobilizing theme "Mobility and health", we wanted to exchange our experiences in this field and especially the contribution of laboratory medicine for the management and prevention of pathologies linked to this mobility, including the covid- 19 pandemic .

Several themes will be covered:

    - Epidemiology and common healthcare interventions

    - Migration and emerging infectious diseases

    - Laboratory diagnostic structures in mobile societies

    - Migration and drug addiction

    - Migration and genetics

    - Molecular biology

    - Mobility of young people in science and health

3 plenary conferences, more than 30 conferences, 30 speakers from 20 countries, 450 posters and several workshops will be organized during this congress.

The scientific committee would like to thank all the persons who actively participated, the members of the steering committee of the two federations, the EFLM works councils, the AFCB, the IFCC EB who agreed to put this congress under its auspices, the STBC, the speakers who responded positively to our invitation despite their country's commitments in the fight against the Covid-19 pandemic and the industrial partners.

 

Président du comité scientifique JNBC

Pr. Brahim Nsiri

 

 

 

 

 

 

 

 

 

    

Président du comité scientifique JNBC

 

Chers collègues, chers amis

Au nom du comité scientifique, il nous fait plaisir de vous souhaiter la bienvenue aux XXXIVèmes Journées Nationales de Biologie Clinique qui vont se dérouler pour cette année parallèlement avec le  1er Congrès Arabo Européen organisé par La Société Tunisienne de Biologie Clinique, la Fédération Européenne de Chimie Clinique et Médecine de Laboratoire (EFLM) et la Fédération Arabe de Biologie Clinique (AFCB). Etant donné les circonstances imposées par la pandémie covid 19, cet événement scientifique important se déroulera en mode virtuel du 18 au 20 Février 2021.

Comme à l’accoutumée, le programme scientifique élaboré par un comité scientifique multidisciplinaire sera dense et diversifié avec toujours la même passion de faire de cette manifestation un forum de formation, d’échanges de connaissances et de débats d’idées.

En pré-congrès, un cours de biologie moléculaire est programmé pour les jeunes biologistes et chercheurs afin de renforcer et perfectionner leurs connaissances dans ce domaine innovant. A sa XIIème édition, ce cours qui devient aujourd’hui une tradition des JNBC sera consacré cette année aux micro-ARN et à la nutrigénétique et bioinformatique.

En plus des symposiums et des communications orales et affichées, trois conférences plénières et deux sessions sont  programmées. Elles seront animées par des spécialistes du domaine et assurées par des experts de renommée internationale et touchant à des thèmes de biologie clinique à la fois judicieux, pertinents et d’actualité.

Le prix Abderraouf Mebazza, figure emblématique de la biologie clinique et fondateur de la STBC, est un prix scientifique décerné en hommage à des pionniers de la biologie clinique en Tunisie. Il sera attribué lors de cette manifestation au meilleur travail scientifique innovant en biologie clinique.

La session de meilleures communications orales sélectionnées à partir des résumés soumis sera clôturée par l’attribution de prix aux trois meilleurs travaux scientifiques présentés lors de ces journées de biologie clinique.

Nous espérons que le programme scientifique sera à la hauteur de vos attentes et suscitera de nombreux échanges tout au long de ces journées de biologie clinique.

Enfin, nous tenons à remercier tous ceux qui ont contribué à la réussite de cette manifestation scientifique, notamment les membres du bureau de la STBC, les conférenciers, les modérateurs des séances, les jurys d’évaluation et de sélection des travaux scientifiques ainsi qu’à tous ceux qui ont participé, de près ou de loin, à l’organisation de ces journées.

Nous serons heureux de vous voir nombreux virtuellement à cet événement scientifique.

Excellent congrès à toutes et à tous.

Très cordialement.

Inscription

Soumission des résumés et des posters

Programme

Espace Exposant